Allen Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $232K | Sell |
471
-195
| -29% | -$106K | ﹤0.01% | 214 |
|
|
2025
Q4 | $386K | Hold |
666
| – | – | ﹤0.01% | 195 |
|
|
2025
Q3 | $323K | Hold |
666
| – | – | ﹤0.01% | 183 |
|
|
2025
Q2 | $270K | Sell |
666
-32
| -5% | -$13.4K | ﹤0.01% | 186 |
|
|
2025
Q1 | $347K | Hold |
698
| – | – | ﹤0.01% | 180 |
|
|
2024
Q4 | $363K | Sell |
698
-1,216
| -64% | -$669K | ﹤0.01% | 180 |
|
|
2024
Q3 | $1.18M | Buy |
1,914
+612
| +47% | +$362K | 0.01% | 138 |
|
|
2024
Q2 | $720K | Buy |
1,302
+604
| +87% | +$346K | 0.01% | 150 |
|
|
2024
Q1 | $406K | Sell |
698
-40
| -5% | -$22.4K | 0.01% | 172 |
|
|
2023
Q4 | $392K | Sell |
738
-16
| -2% | -$7.75K | 0.01% | 179 |
|
|
2023
Q3 | $382K | Hold |
754
| – | – | 0.01% | 186 |
|
|
2023
Q2 | $393K | Hold |
754
| – | – | 0.01% | 174 |
|
|
2023
Q1 | $435K | Buy |
754
+195
| +35% | +$110K | 0.01% | 166 |
|
|
2022
Q4 | $308K | Sell |
559
-71
| -11% | -$37.6K | ﹤0.01% | 186 |
|
|
2022
Q3 | $320K | Buy |
630
+84
| +15% | +$47K | 0.01% | 181 |
|
|
2022
Q2 | $297K | Hold |
546
| – | – | ﹤0.01% | 200 |
|
|
2022
Q1 | $322K | Hold |
546
| – | – | ﹤0.01% | 208 |
|
|
2021
Q4 | $364K | Hold |
546
| – | – | ﹤0.01% | 200 |
|
|
2021
Q3 | $312K | Hold |
546
| – | – | ﹤0.01% | 178 |
|
|
2021
Q2 | $275K | Hold |
546
| – | – | ﹤0.01% | 171 |
|
|
2021
Q1 | $249K | Hold |
546
| – | – | ﹤0.01% | 178 |
|
|
2020
Q4 | $254K | Buy |
546
+8
| +1% | +$3.75K | ﹤0.01% | 172 |
|
|
2020
Q3 | $238K | Buy |
+538
| New | +$222K | ﹤0.01% | 171 |
|
|
2016
Q2 | – | Sell |
-34,778
| Closed | -$4.92M | – | 230 |
|
|
2016
Q1 | $4.92M | Sell |
34,778
-1,261
| -3% | -$169K | 0.39% | 36 |
|
|
2015
Q4 | $5.11M | Sell |
36,039
-367
| -1% | -$49K | 0.43% | 38 |
|
|
2015
Q3 | $4.45M | Buy |
36,406
+718
| +2% | +$93.5K | 0.43% | 41 |
|
|
2015
Q2 | $4.63M | Buy |
35,688
+7,613
| +27% | +$992K | 0.44% | 40 |
|
|
2015
Q1 | $3.77M | Buy |
28,075
+1,503
| +6% | +$194K | 0.28% | 59 |
|
|
2014
Q4 | $3.33M | Buy |
26,572
+5,157
| +24% | +$627K | 0.25% | 61 |
|
|
2014
Q3 | $2.61M | Buy |
21,415
+120
| +0.6% | +$14.6K | 0.22% | 67 |
|
|
2014
Q2 | $2.51M | Sell |
21,295
-12,564
| -37% | -$1.48M | 0.26% | 63 |
|
|
2014
Q1 | $4.07M | Buy |
33,859
+19,132
| +130% | +$2.27M | 0.63% | 41 |
|
|
2013
Q4 | $1.64M | Buy |
14,727
+700
| +5% | +$69.6K | 0.35% | 48 |
|
|
2013
Q3 | $1.29M | Buy |
+14,027
| New | +$1.27M | 0.35% | 39 |
|
Other funds holding TMO
VCM
Allen Investment Management's TMO Position: Q1 2026 in Review
Allen Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 29% in Q1 2026, selling an estimated $106K and leaving 471 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #214.
Allen Investment Management first reported a position in TMO in Q3 2013 and has held it in 34 quarters since. The position peaked at $5.11M in Q4 2015. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Allen Investment Management held 471 shares of Thermo Fisher Scientific worth $232K as of Q1 2026.
- Allen Investment Management sold 195 Thermo Fisher Scientific shares in Q1 2026, an estimated $106K.
- Thermo Fisher Scientific made up ﹤0.01% of Allen Investment Management's portfolio in Q1 2026, its #214 holding.
- Allen Investment Management first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 34 quarters since.
- Allen Investment Management's Thermo Fisher Scientific position peaked at $5.11M in Q4 2015.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Allen Investment Management's 13F filing for Q1 2026, filed 7 May 2026.